Daniel O. Wilds

Daniel O. Wilds was elected to our board of directors in December 2002. He currently serves as President and Chief Executive Officer of SCOLR Pharma, Inc. a biopharmaceutical company focusing on the controlled release of pharmaceuticals and nonprescription supplements. From 1998 until 2003 Mr. Wilds served as President of Northwest Biotherapeutics, Inc. Prior to joining Northwest Biotherapeutics, Mr. Wilds was President and Chief Executive Officer of Shiloov Biotechnologies (USA), Inc., from July 1997 to January 1998. Mr. Wilds holds a B.A. from California State University, Los Angeles and a M.B.A. from Northwestern University.